Rate of cross-commodity discounting of substances varies by substance type for individuals in recovery from substance use disorders.
Experimental and Clinical Psychopharmacology · 2025
DOI: 10.1037/pha0000780 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental and Clinical Psychopharmacology, 2025. Verfasst von Anthony N Nist und 4 weiteren Autor:innen. Beteiligte Einrichtung: Addiction Recovery Research Center, Fralin Biomedical Research Institute, Virginia Tech Carilion. Hauptthemen laut MEDLINE: Substance-Related Disorders, Delay Discounting. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAAA NIH HHS, National Institutes of Health; National Institute on Alcohol Abuse and Alcoholism, Virginia Tech Carilion; Fralin Biomedical Research Institute.
Abstract (Originalsprache)
The extant literature hints at the existence of substance-specific differences in rates of cross-commodity discounting (CCT). However, direct examinations are currently lacking. The present experiment aimed to replicate previous studies examining CCT of substances and to extend their findings by examining potential substance-specific relationships with discounting. Participants (n = 122) on recovery pathways from substance use disorders indicated the substances they were still actively using and then ranked these substances from most to least preferred. Participants then completed four discounting tasks: (a) money now-money later, (b) money now-drug later, (c) drug now-drug later, and (d) drug now-money later. Monetary and drug amounts were always equated. In these tasks, the drug commodity was always the participant's most preferred except if participants indicated they used multiple substances, in which case they completed additional discounting tasks with their second most preferred substance. Results revealed that discounting rates across substances did not differ significantly in conditions where the same commodity was both the immediate and the delayed option. In contrast, in the drug now-money later condition, we found that rates of discounting varied significantly according to the specific drug commodity. Further, this relationship was inverted in the money now-drug later condition. Overall, results from previous examinations of the CCT of alcohol and stimulants were replicated. In addition, we provide the first direct evidence that rates of CCT may differ across different substances. (PsycInfo Database Record (c) 2025 APA, all rights reserved).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Addiction Recovery Research Center, Fralin Biomedical Research Institute, Virginia Tech Carilion.
Förderung
- NIAAA NIH HHS
- National Institutes of Health; National Institute on Alcohol Abuse and Alcoholism
- Virginia Tech Carilion; Fralin Biomedical Research Institute
- Virginia Tech Carilion
- National Institutes of Health
Zitieren
APA
Nist, A. N., Cabral, D. A. R., Xu, S., Tegge, A. N., & Bickel, W. K. (2025). Rate of cross-commodity discounting of substances varies by substance type for individuals in recovery from substance use disorders. Experimental and Clinical Psychopharmacology. https://doi.org/10.1037/pha0000780
Vancouver
Nist AN, Cabral DAR, Xu S, Tegge AN, Bickel WK. Rate of cross-commodity discounting of substances varies by substance type for individuals in recovery from substance use disorders. Experimental and Clinical Psychopharmacology. 2025. doi:10.1037/pha0000780
BibTeX
@article{Nist2025,
author = {Nist, Anthony N and Cabral, Daniel A R and Xu, Shuangshuang and Tegge, Allison N and Bickel, Warren K},
title = {Rate of cross-commodity discounting of substances varies by substance type for individuals in recovery from substance use disorders},
journal = {Experimental and Clinical Psychopharmacology},
year = {2025},
doi = {10.1037/pha0000780}
}
EUVIMED